1. Home
  2. NIE vs VALN Comparison

NIE vs VALN Comparison

Compare NIE & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Equity & Convertible Income Fund of Beneficial Interest

NIE

Virtus Equity & Convertible Income Fund of Beneficial Interest

HOLD

Current Price

$25.33

Market Cap

655.6M

Sector

Finance

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.00

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NIE
VALN
Founded
2007
2012
Country
United States
France
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
655.6M
536.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NIE
VALN
Price
$25.33
$6.00
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$16.00
AVG Volume (30 Days)
78.4K
144.4K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
9.04%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.11
$5.43
52 Week High
$26.00
$12.25

Technical Indicators

Market Signals
Indicator
NIE
VALN
Relative Strength Index (RSI) 65.88 28.85
Support Level $24.75 $5.88
Resistance Level $25.62 $6.73
Average True Range (ATR) 0.40 0.26
MACD 0.23 0.10
Stochastic Oscillator 95.82 21.38

Price Performance

Historical Comparison
NIE
VALN

About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest

Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. The investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments, such as aerospace and defense, banks, IT services, software, and others.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: